You can tell the fight between Allergan, Inc. (NYSE:AGN) and Valeant Pharmaceuticals Intl Inc (NYSE:VRX) (TSE:VRX) is coming down to the wire. With a December proxy vote looming, both sides have fought what can only be considered a historic battle.
Some of the key points in the battle are addressed in the to be unredacted confidential documents and emails primarily paint a picture of an intense battle.
ValueWalk has separated the key documents into a Valeant Pharmaceuticals Intl Inc (NYSE:VRX) (TSE:VRX) and Allergan, Inc. (NYSE:AGN) camp, along with a few general observations.
Questions buzzing around Ackman's involvement in purchasing Allergan stock
There were two questions buzzing around hedge fund circles Setup a free account to get access to this article (no credit card required).Login required to continue reading.
